Dexcom stock plummeting is an ‘opportunity to add to positions’, says Wolfe Research’s Mike Polark

Mike Polark, Wolfe Research, joins ‘Closing Bell Overtime’ to talk Dexcom shares plummeting on Q2 results and how to play the stock.